Senescence Life Sciences
Senescence Life Sciences is a biotechnology company dedicated to redefining and optimizing brain health and performance through novel nutritional products and therapeutics. Supported by world-renowned scientists and business leaders, it leverages cellular and molecular neuroscience to address age-related cognitive decline and neurodegenerative diseases, aiming to restore classical neuronal indicators of age and improve cognitive performance.
Industries
Nr. of Employees
small (1-50)
Patents
Compositions and methods for the treatment and prevention of cognitive decline and preservation of neuronal function
US-11278519-B2
View Details
Compositions and methods for the treatment and prevention of cognitive decline and preservation of neuronal function
US-11278519-B2
View DetailsProducts
Consumer nutraceutical formulations for cognitive support
Market-ready supplement formulations designed to improve brain health and cognitive performance, offered in multiple formats and supported by clinical research.
Performance-focused nootropic drink formulation (in development)
A novel drink formulation intended to improve reaction time, focus and spatial awareness, developed as a lower-sugar alternative to energy drinks and targeted at athletes and e-sports professionals; clinical testing was planned.
Pharmaceutical pipeline targeting lipid dysfunction in neurodegeneration
Pre-clinical drug candidates aimed at preventing or treating Alzheimer’s disease by targeting lipid dysfunction and cellular repair pathways upstream of amyloid production.
Consumer nutraceutical formulations for cognitive support
Market-ready supplement formulations designed to improve brain health and cognitive performance, offered in multiple formats and supported by clinical research.
Performance-focused nootropic drink formulation (in development)
A novel drink formulation intended to improve reaction time, focus and spatial awareness, developed as a lower-sugar alternative to energy drinks and targeted at athletes and e-sports professionals; clinical testing was planned.
Pharmaceutical pipeline targeting lipid dysfunction in neurodegeneration
Pre-clinical drug candidates aimed at preventing or treating Alzheimer’s disease by targeting lipid dysfunction and cellular repair pathways upstream of amyloid production.
Services
B2B white-label product formulation and supply for third-party brands, with multi-format product options and emphasis on purity and consistency.
Partnership-based research services to support pre-clinical development, pilot clinical trials and evidence generation for neuroprotective compounds and formulations.
Establishing distribution agreements and commercial partnerships for brain-health ingredients and formulations.
B2B white-label product formulation and supply for third-party brands, with multi-format product options and emphasis on purity and consistency.
Partnership-based research services to support pre-clinical development, pilot clinical trials and evidence generation for neuroprotective compounds and formulations.
Establishing distribution agreements and commercial partnerships for brain-health ingredients and formulations.
Expertise Areas
- Clinical trial management
- Pre-clinical drug development for neurodegeneration
- Nutraceutical formulation and product development
- Lipid-focused neuroscience research
Key Technologies
- Lipid-targeted molecular therapeutics
- Mechanism-based neuroprotective compound discovery
- Nutraceutical formulation technology
- Preclinical efficacy models for neurodegeneration